These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 19246102)

  • 1. Meta-analysis of the placebo response in antidepressant trials.
    Rief W; Nestoriuc Y; Weiss S; Welzel E; Barsky AJ; Hofmann SG
    J Affect Disord; 2009 Nov; 118(1-3):1-8. PubMed ID: 19246102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment effects of antidepressants in patients with post-stroke depression: a meta-analysis.
    Chen Y; Guo JJ; Zhan S; Patel NC
    Ann Pharmacother; 2006 Dec; 40(12):2115-22. PubMed ID: 17119102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Placebo effect in the drug therapy of depression].
    Hougaard E; Nielsen T; Zachariae B
    Ugeskr Laeger; 2000 Apr; 162(16):2314-7. PubMed ID: 10827560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placebo response and antidepressant clinical trial outcome.
    Khan A; Detke M; Khan SR; Mallinckrodt C
    J Nerv Ment Dis; 2003 Apr; 191(4):211-8. PubMed ID: 12695731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is drug-placebo difference in short-term antidepressant drug trials on unipolar major depression much greater than previously believed?
    Rihmer Z; Gonda X
    J Affect Disord; 2008 Jun; 108(3):195-8. PubMed ID: 18280581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of reboxetine as an antidepressant, a meta-analysis of both continuous (mean HAM-D score) and dichotomous (response rate) outcomes.
    Chuluunkhuu G; Nakahara N; Yanagisawa S; Kamae I
    Kobe J Med Sci; 2008 Jul; 54(2):E147-58. PubMed ID: 18772616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.
    Papakostas GI; Fava M
    Eur Neuropsychopharmacol; 2009 Jan; 19(1):34-40. PubMed ID: 18823760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The persistence of the placebo response in antidepressant clinical trials.
    Khan A; Redding N; Brown WA
    J Psychiatr Res; 2008 Aug; 42(10):791-6. PubMed ID: 18036616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-placebo difference: in antidepressant drug trials could be 50% greater than previously believed.
    Rihmer Z
    Neuropsychopharmacol Hung; 2007 Mar; 9(1):35-7. PubMed ID: 17879563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms.
    Mercer D; Douglass AB; Links PS
    J Pers Disord; 2009 Apr; 23(2):156-74. PubMed ID: 19379093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mousetrap: managing the placebo effect in antidepressant trials.
    Lakoff A
    Mol Interv; 2002 Apr; 2(2):72-6. PubMed ID: 14993352
    [No Abstract]   [Full Text] [Related]  

  • 12. Antidepressant prophylaxis for poststroke depression: a meta-analysis.
    Chen Y; Patel NC; Guo JJ; Zhan S
    Int Clin Psychopharmacol; 2007 May; 22(3):159-66. PubMed ID: 17414742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Larger effect sizes were associated with higher quality ratings in complementary and alternative medicine randomized controlled trials.
    Bausell RB; Lee WL; Soeken KL; Li YF; Berman BM
    J Clin Epidemiol; 2004 May; 57(5):438-46. PubMed ID: 15196613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
    Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Placebo-controlled antidepressant drug trials. Considering the ethical implications].
    Deisenhammer EA; Hinterhuber H
    Fortschr Neurol Psychiatr; 2003 May; 71(5):243-8. PubMed ID: 12740755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The relationship between the placebo effect and spontaneous improvement in research on antidepressants. Are placebos powerless?].
    Hougaard E
    Ugeskr Laeger; 2005 Aug; 167(32):2865-9. PubMed ID: 16109187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder.
    Bridge JA; Birmaher B; Iyengar S; Barbe RP; Brent DA
    Am J Psychiatry; 2009 Jan; 166(1):42-9. PubMed ID: 19047322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The enrichment window approach as a means of dealing with placebo response in antidepressant clinical trials.
    Mallinckrodt CH; Prucka WR
    Clin Pharmacol Ther; 2010 Nov; 88(5):592-4. PubMed ID: 20959845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of placebo response with major depressive disorder in patients recruited through newspaper advertising versus consultation referrals.
    Miller CA; Hooper CL; Bakish D
    Psychopharmacol Bull; 1997; 33(4):647-51. PubMed ID: 9493474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Delay of the antidepressant effect: clinical studies].
    Escande M; Gentil V; Frexinos M
    Encephale; 1995 Mar; 21 Spec No 2():3-8. PubMed ID: 7588175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.